Europe / Top 5 Pharma R&D Spenders
The Top Five countries in Europe ranked by amount spent on pharma R&D. While some of the continent’s largest…
IGES
Last updated: 13.02.2014
Address: Friedrichstraße 180, Berlin 10117,Germany
Tel: +49-(0)30 / 230 80 90
Web: http://www.iges.de/
Company description
IGES was founded in 1980 as a company for research and development in health-related matters; it also offers consultancy services. Its predecessor was the Berlin working group for structural research in health-related matters – Berliner Arbeitsgruppe Strukturforschung im Gesundheitswesen (BASiG) – an institution of the Berlin Technical University. Today it is Germany’s largest private R&D institute for health and healthcare.
Products and services
Related
Europe / Health Technology Assessment in the EU: Back and Forth in Giant Strides
Writing in the August edition of DIA’s Global Forum, Sanofi R&D’s Thomas Kühler outlines the bumpy…
Europe / New EFPIA President Hubertus von Baumbach on Building Back Better from COVID & a Healthier European Future
Boehringer Ingelheim’s Hubertus von Baumbach, the newly appointed president of the European Federation of…
Germany / Merck KGaA Expecting More COVID-Related Deals; Digital Health Woes; CureVac Vaccine Potential vs Variants
The latest news from German pharma, including a new US leadership team and more COVID-related investment at Merck…
Germany / Highest Honours for BioNTech Founders; Bayer’s Growth Predictions; Merck Making Further French Investments
A roundup of some of the most important recent news from German pharma, including state honours for the founders of…
Germany / STADA’s Bold Bets on M&A
After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness…
Germany / The Biotech Behind Pfizer’s COVID-19 Vaccine Candidate
German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant…
Pharma Faces / Teresa Rodó, Head of Global Healthcare Operations, Merck
PharmaBoardroom recently sat down with Merck’s EVP and Head of Global Healthcare Operations, Teresa Rodó to…
Merck KGaA / Big-Ticket Investments in Manufacturing Scale & Digital Innovation
Merck KGaA has moved to continuously expand its manufacturing capacity and capability in recent years with a number…
Europe / A New Approach to Health Crises in France & Germany
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would…
News Roundup / German Pharma: February 2020
Some of the top recent stories from Germany, Europe’s leading pharma market according to CPhI, including big…
Bayer: Betting Big on Cell & Gene Therapy
Bayer’s latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as…
